CRYOcheck™ Factor VIII Deficient Plasma with VWF for use as a deficient substrate in clot-based factor VIII (FVIII) activity assays 25x1.0mL

CRYOcheck™ Factor VIII deficient plasma with Von Willebrand Factor (VWF) is for clinical laboratory use as a deficient substrate, in the one-stage activated partial thromboplastin time (APTT) method. It is used to quantitatively identify FVIII deficiency and as an aid in the management of haemophilia A in 3.2% citrated human plasma for patients aged 2 years and older.

The product has been manufactured from platelet-poor plasma, which has been immunodepleted of FVIII and which container normal levels of VWF. FVIII has been assayed at less than 1% normal antigen and activity levels, with VWF antigen and activity levels are >50%. The source plasma is screened negative for all FDA-required tests. CRYOcheck™ Factor VIII deficient plasma with VWF has the highest proportion of active VWF and lowest amount of inactive FVIII antigen, making it most comparable to congenital deficient plasma.

The plasma is buffered and frozen, with the frozen format eliminating reconstitution errors and a 24-hour stability once thawed if refrigerated at 2°C-8°C in the original capped vial.

Specification:
Vial size: 1.0mL
Quantity per pack: 25
Storage: between -40°C to -80°C
Stability: 24 hours once thawed if refridgerated at 2°C-8°C
Expiry: 1 year from manufacturing date